Compare · LMAT vs MDLN
LMAT vs MDLN
Side-by-side comparison of LeMaitre Vascular Inc. (LMAT) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LMAT and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $58.42B, about 23.3x LMAT ($2.51B).
- Over the past year, LMAT is up 21.2% and MDLN is up 9.1% - LMAT leads by 12.1 points.
- LMAT has been more active in the news (6 items in the past 4 weeks vs 5 for MDLN).
- MDLN has more recent analyst coverage (25 ratings vs 16 for LMAT).
- Company
- LeMaitre Vascular Inc.
- Medline Inc.
- Price
- $109.56+2.25%
- $44.47+2.49%
- Market cap
- $2.51B
- $58.42B
- 1M return
- +0.21%
- -0.07%
- 1Y return
- +21.18%
- +9.13%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2006
- 2025
- News (4w)
- 6
- 5
- Recent ratings
- 16
- 25
LeMaitre Vascular Inc.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; powered phlebectomy devices to remove varicose veins; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers remote endarterectomy devices to remove plaque from arteries in the leg; valvulotomes, which cut valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular patches, which are used for closure of vessels after surgical intervention; closure systems to attach vessels to one another with titanium clips instead of sutures; and surgical glue. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
Latest LMAT
- Director Pellegrino Joseph P Jr exercised 2,941 shares at a strike of $35.48, increasing direct ownership by 24% to 15,021 units (SEC Form 4)
- LeMaitre Will Announce First Quarter 2026 Earnings Results on May 5, 2026
- SEC Form DEFA14A filed by LeMaitre Vascular Inc.
- SEC Form DEF 14A filed by LeMaitre Vascular Inc.
- LeMaitre Vascular Inc. filed SEC Form 8-K: Leadership Update
- LeMaitre to Present at the 25th Annual Needham Virtual Healthcare Conference
- SEC Form 4 filed by Shadan Martha
- SEC Form 4 filed by Ross Bridget A
- SEC Form 4 filed by O'Connor John James
- SEC Form 4 filed by Roush John A
Latest MDLN
- SEC Form DEFA14A filed by Medline Inc.
- SEC Form DEF 14A filed by Medline Inc.
- Medline announces first-in-healthcare AI robotics partnership with Symbotic
- Medline to report first quarter 2026 results on May 6, 2026
- Medline launches custom product fulfillment technology called Pick Pack Pro™
- Medline recognizes manufacturing facilities with Golden Cone Safety Award
- Medline receives HIRC Member Choice Awards for supply chain achievement and renews Transparency Badge distinction
- Director Healy Patrick J acquired 577,510 shares, increasing direct ownership by 73% to 1,208,159 units (SEC Form 4)
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,058,524,148 worth of shares (26,131,237 units at $40.51) and disposed of 2,088,086 shares (SEC Form 4)
- Large owner Cp Circle Ml Holdco Gp, Llc sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)